{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-023130","form_type":"8-K","ticker":"ADPT","cik":"0001478320","company_name":"Adaptive Biotechnologies Corp","filed_at":"2022-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.859352+00:00","generated_at":"2026-06-25T01:57:55.377612+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Adaptive Biotech shareholders elect three Class III directors, approve advisory compensation, ratify auditor","bullets":["Chad Robins, Kevin Conroy, Michael Pellini elected as Class III directors to 2025 term.","Advisory vote on 2021 NEO compensation approved: 72.7M for, 44.5M against, 298k abstentions.","Ernst & Young ratified as independent auditor for FY2022: 129.8M for, 55k against, 71k abstentions.","All proposals passed at June 10, 2022 annual meeting; no broker non-votes for auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-023130","json":"https://secwatch.observer/filing/0001564590-22-023130.json","markdown":"https://secwatch.observer/filing/0001564590-22-023130.md","text":"https://secwatch.observer/filing/0001564590-22-023130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478320/000156459022023130/0001564590-22-023130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478320/000156459022023130/adpt-8k_20220610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:57:55.377612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}